Biocon Biologics receives MHRA UK approval for Vevzuo and Evfraxy, Denosumab Biosimilars
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
This approval has come from the company's finished dosage form manufacturing facility
Subscribe To Our Newsletter & Stay Updated